Contents

  1. Asbestos Exposure Assessment, Risk Identification, and Substitutes


1-A Asbestos Hazard Identification (UOEH) [Original Reference ]
1-B Asbestos Exposure Assessment and Control in Occupational Settings (KOSHA)
1-B-a Methodologies related to environmental
monitoring of asbestos
[Original Reference ]
1-B-a-1 Determination of airborne fibre number concentration: a recommended method by phase-contrast optical microscopy (membrane filter method)
1-B-a-2 Asbestos and other fibers by PCM. NMAM 7400
1-B-a-3 Asbestos in air
1-B-a-4 Fibres in air: sampling and evaluation of by phase contrast microscopy (PCM) Asbestos: the analysts' guide for sampling, analysis and clearance procedures
1-B-a-5 Guidance note on the membrane filter method for estimating airborne asbestos fibres
1-B-a-6 Determination of airborne fibrous particles – Part 1: optical microscopy method and scanning electron microscopy (SEM) method
1-B-a-7 Asbestos by TEM. NMAM 7402
1-B-a-8 Interim TEM analytical methods
1-B-a-9 Ambient air – determination of asbestos fibres – direct-transfer TEM method
1-B-a-10 Ambient air – determination of asbestos fibres – indirect-transfer TEM method
1-B-a-11 Standard practice for sampling and counting airborne fibers, including asbestos fibers, in the workplace, by phase contrast microscopy (PCM; with the option of transmission electron microscopy; TEM)
1-B-a-12 Standard test method for airborne asbestos concentration in ambient and indoor atmospheres as determined by transmission electron microscopy direct transfer (TEM)
1-B-a-13 Determination of numerical concentration of inorganic fibrous particles – SEM method
1-B-a-14 Asbestos (bulk) by PLM. NMAM 9002
1-B-a-15 Polarized light microscopy (PLM) of asbestos
1-B-a-16 Method for the determination of asbestos in bulk building materials
1-B-a-17 Asbestos in bulk materials: sampling and identification by polarized light microscopy (PLM)
1-B-a-18 Method for the qualitative identification of asbestos in bulk samples
1-B-a-19 Asbestos, chrysotile by XRD. NMAM 9000
1-B-a-20 Determination of asbestos in building material products
1-B-b Work practices for preventing asbestos exposure [Original Reference ]
1-B-b-1 Safety in the use of asbestos: an ILO code of practice
1-B-b-2 Asbestos, 29 CFR 1910.1001
1-B-b-3 Asbestos, 29 CFR 1926.1101
1-B-b-4 Asbestos, 29 CFR 1915.1001
1-B-b-5 Guidance for controlling asbestos-containing materials in buildings
1-B-b-6 How to manage asbestos in school buildings: The AHERA designated person's self study guide
1-B-b-7 Asbestos essentials
1-B-b-8 A comprehensive guide to managing asbestos in premises
1-B-b-9 Safe work practices for handling asbestos
1-B-b-10 Safe work practices for asbestos laboratories
1-B-c Asbestos exposure levels of various situations and conditions [Original Reference ]

1-C Epidemiology of ARDs (UOEH)
1-C-1 Towards elimination of asbestos-related diseases: a theoretical basis for international cooperation
1-C-2 The global burden of diseases due to occupational carcinogens
1-C-3 The European mesothelioma epidemic
1-C-4 The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
1-C-5 Asbestosis mortality in the USA: facts and predictions
1-C-6 A review of human carcinogens part C: arsenic, metals, fibres, and dusts
1-C-7 Are current or future mesothelioma epidemics in Hong Kong the tragic legacy of uncontrolled use of asbestos in the past?
1-C-8 Asbestosis and mesothelioma among British asbestos workers (1971–2005)
1-C-9 Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register
1-C-10 Projected mesothelioma incidence in men in New South Wales
1-C-11 Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates
1-C-12 Asbestosis-related years of potential life lost before age 65 years – United States, 1968–2005
1-C-13 Relation between lung asbestos fibre burden and exposure indices based on job history
1-C-14 Cancer incidence and asbestos in drinking water, Town of Woodstock, New York, 1980–1998
1-C-15 The mesothelioma epidemic in Western Europe: an update
1-C-16 Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study
1-C-17 Cohort mortality study of women compensated for asbestosis in Italy
1-C-18 Ovarian cancer and occupational exposures in Finland
1-C-19 Clinical study on mesothelioma in Japan: relevance to occupational asbestos exposure
1-C-20 Mapping the risk of mesothelioma due to neighborhood asbestos exposure
1-C-21 Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferato, Italy
1-C-22 Increased risk of lung cancer mortality among residents near asbestos product manufacturing plant
1-C-23 Occupational asbestos exposure among respiratory cancer patients in Lithuania
1-C-24 Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study
1-C-25 Cancer risk after cessation of asbestos exposure: a cohort study of Italian asbestos cement workers
1-C-26 Mortality among shipyard Coast Guard workers: a retrospective cohort study
1-C-27 Asbestos related mortality in Northern Ireland: 1985–1994
1-C-28 Low-dose exposure to asbestos and lung cancer: dose-response relations and interaction with smoking in a population-based case-referent study in Stockholm, Sweden
1-C-29 Occupational airborne exposure and the incidence of respiratory symptoms and asthma
1-C-30 Cancer incidence among workers in the asbestos-cement producing industry in Norway
1-C-31 Explaining Alberta’s rising mesothelioma rates
1-C-32 Occupational exposure to asbestos and mortality among asbestos removal workers: a Poisson regression analysis
1-C-33 Asbestos burden predicts survival in pleural mesothelioma
1-C-34 Non-occupational exposure to asbestos and malignant mesothelioma in the Italian National Registry of Mesotheliomas
1-C-35 Occupational asbestos exposure and digestive cancers – a cohort study
1-C-36 Mortality of former crocidolite (blue asbestos) miners and millers at Wittenoom
1-C-37 Mortality from all cancers of asbestos factory workers in east London 1933–1980
1-C-38 Chest pain in asbestos and silica-exposed workers
1-C-39 Incidence trends and gender differences in malignant mesothelioma in New South Wales, Australia
1-C-40 Asbestos exposure among Seoul metropolitan subway workers during renovation of subway air-conditioning systems
1-C-41 The French national mesothelioma surveillance program
1-C-42 Exposure of UK industrial plumbers to asbestos, part 1: monitoring of exposure using personal passive samplers
1-C-43 Asbestos release from whole-building demolition of buildings with asbestos-containing material
1-C-44 Exposure to chrysotile asbestos associated with unpacking and repacking boxes of automobile brake pads and shoes
1-C-45 Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
1-C-46 The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, Western Australia
1-C-47 Personal and static sample measurements of asbestos fibers during two abatement projects
1-C-48 Risk assessment of the decay of asbestos cement roofs
1-C-49 Assessment of cancer risks due to environmental exposure to asbestos
1-C-50 Global use of asbestos and the incidence of mesothelioma
1-C-51 Comparison of lung asbestos fiber content in cancer subjects with healthy individuals with no known history of occupational asbestos exposure in Korea
1-C-52 The rise and fall in incidence of malignant mesothelioma from a British Naval Dockyard, 1979–1999
1-C-53 Modeling mesothelioma risk associated with environmental asbestos exposure
1-C-54 South Africa’s export trade in asbestos: demise of an industry
1-C-55 Occupation and risk of malignant pleural mesothelioma: a case-control study in Spain
1-C-56 Occupations and industries in France at high risk for pleural mesothelioma: a population-based case-control study (1998–2002)
1-C-57 Attributable risk in men in two French case-control studies on mesothelioma and asbestos
1-C-58 Asbestos-related cancers among 28,300 military servicemen in the Royal Norwegian Navy
1-C-59 Asbestos-related occupational cancers compensated under the industrial accident compensation insurance in Korea
1-C-60 Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers
1-C-61 Cancer mortality among workers exposed to amphibole-free chrysotile asbestos
1-C-62 Pulmonary function in long-term asbestos workers in China
1-C-63 Lung fiber burden in the Nottingham gas mask cohort
1-C-64 Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos
1-C-65 Residential proximity to naturally occurring asbestos and mesothelioma risk in California
1-C-66 The effect of smoking on the risk of lung cancer mortality for asbestos workers in Great Britain (1971–2005)
1-C-67 Mortality among British asbestos workers undergoing regular medical examinations (1971–2005)
1-C-68 Patterns of pulmonary dysfunction in asbestos workers: a cross-sectional study
1-C-69 Surveillance of Australian workplace based respiratory events (SABRE) in New South Wales
1-C-70 Occupational asbestos exposure as a risk factor for laryngeal carcinoma in a population-based case-control study from Germany
1-C-71 Estimating the number of asbestos-related lung cancer deaths in Great Britain from 1980 to 2000
1-C-72 Under-reporting of compensable mesothelioma in Alberta
1-C-73 Asbestos in Poland: occupational health problems
1-C-74 Global magnitude of reported and unreported mesothelioma
1-C-75 National use of asbestos in relation to economic development
1-C-76 Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis
1-C-77 Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment
1-C-78 Asbestos-related diseases: time for technology sharing

1-D High Risk Occupation and Industries in regards to ARDS (KOSHA) [Original Reference ]
1-D-1 Occupational exposure to carcinogens in the European Union in 1990–93
1-D-2 Occupational exposure to carcinogens in the European Union
1-D-3 An asbestos job exposure matrix to characterize fiber type, length, and relative exposure intensity
1-D-4 Incidence and use of asbestos, technical prevention
1-D-5 Asbestos consumption, asbestos exposure and asbestos-related occupational diseases in Germany
1-D-6 Linking expert judgement and trends in occupational exposure into a job-exposure matrix for historical exposure to asbestos in the Netherlands
1-D-7 An expert system for the evaluation of historical asbestos exposure as diagnostic criterion in asbestos-related diseases
1-D-8 Trends in occupational asbestos exposure and asbestos consumption over recent decades in Korea
1-D-9 The work-related lung disease surveillance report, 2007
1-D-10 Mesothelioma mortality in Great Britain from 1968 to 2001
1-D-11 Occupational, domestic and environmental mesothelioma risks in Britain: a case-control study
1-D-12 Malignant mesothelioma –German mesothelioma register 1987–1999
1-D-13 An occupation-industry matrix analysis of mesothelioma cases in Australia 1980–1985
1-D-14 Distribution of mesothelioma cases in different occupational groups and industries in Australia, 1979–1995
1-D-15 Epidemiology of occupational asbestos-related diseases in China
1-D-16 Asbestos in the non-mining industry on the Witwatersrand, South Africa
1-D-17-1 Asbestos and other occupational Lung diseases in New Zealand
1-D-17-2 Asbestos exposure and disease: notes for medical practitioners

1-E Asbestos Substitute (KOSHA) [Original Reference ]
1-E-1 Asbestos: protecting the future and coping with the past
1-E-2 U.S Geological Survey: asbestos (geology, mineralogy, mining, and uses)
1-E-3 Good practice note: asbestos: occupational and community health issues
1-E-4 Testing of fibrous particles: short-term assays
1-E-5 The development of a substitute for asbestos gasket material
1-E-6~12 United State Patents related to technology and development of asbestos-free materials
1-E-13 Report of the World Health Organization workshop on mechanisms of fibre carcinogenesis and assessment of chrysotile asbestos substitutes
1-E-14~15 IARC Monographs on the evaluation of carcinogenic risk to humans: silica, some silicates, coal dust and para-aramid fibrils/man-made vitreous fibres
1-E-16 Comparative hazards of chrysotile asbestos and its substitutes: a European perspective
1-E-17 Report on the expert panel on health effects of asbestos and synthetic vitreous fibers: the influence of fiber length
1-E-18 NIOSH Respiratory Disease Research Program; evidence package for the national academies' review 2006–2007: fiber-induced disease
1-E-19 Documentations of the threshold limit values (TLVs) for chemical substances and physical agents and biological exposure indices (BEIs): synthetic vitreous fibers
1-E-20 Effects of fiber characteristics on lung deposition, retention, and disease
1-E-21 Safety in the use of synthetic vitreous fibre insulation wools (glass wool, rock wool, slag wool)
1-E-22 NIOSH Mineral Fibers Work Group: asbestos and other mineral fibers: a roadmap for scientific research